drugset / Trial / NCT04856098
Absorption of Indacaterol and Glycopyrronium From Ultibro Breezhaler
RandomizedCrossoverOpen-labelBasic science
Summary
The objective of this study is to assess pharmacokinetics (PK) of indacaterol and glycopyrronium, and methodology and practical arrangements for future studies.
Timeline
- Start
- 2021-05-07
- Primary completion
- 2021-09-21
- Completion
- 2021-09-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrronium | Unknown | 43 ug | Inhaled |
| Subject | Glycopyrronium | Unknown | 86 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 85 ug | Inhaled |
| Subject | Indacaterol | Other / unclassified | 170 ug | Inhaled |
| Background | Activated Charcoal | Other / unclassified | — | Oral |
Indications
No indication recorded.